The Latest Regenerative Medicine Articles from Streetwise Reports
Regenerative Medicine Firm Reports Positive Chronic Lower Back Pain Trial Results
Research Report
New study data and next steps for Mesoblast's MPC-06-ID are presented in a Dawson James Securities report.
read more >
Analyst: Differences Between Two Possible COVID-19 Therapies Noteworthy
Research Report
The factors that set Athersys' stem cell product MultiStem apart from a competitor's therapeutic are provided in a Dawson James Securities report.
read more >
Organogenesis Shares Rise 20% on Q3 Net Revenue Growth and FY Guidance
Shares of Organogenesis Holdings traded higher after the company reported preliminary Q3/20 financial results demonstrating a 55% increase in year-over-year revenue. read more >Phase 3 COVID-19 Study of Firm's Stem Cell Product Exceeds 50% Enrollment
Research Report
The study design and goals and Mesoblast's next steps are reviewed in a Dawson James Securities report.
read more >
Showing Results: 1 to 4 of 4